F. Kevin Dye
Financieel Directeur/CFO bij Advanced Catheter Therapies, Inc.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Paul J. Fitzpatrick | M | - |
Advanced Catheter Therapies, Inc.
 Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | 16 jaar |
| Dirk V. Hoyns | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | 16 jaar |
| David A. Belitz | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
| C. Rex Teeslink | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | 16 jaar |
| J. Scott Adams | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
| Frank Bunch | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
| Henry Krebs | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 7 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- F. Kevin Dye
- Persoonlijk netwerk
